Literature DB >> 18412327

Structural origin of selectivity in class II-selective histone deacetylase inhibitors.

Guillermina Estiu1, Edward Greenberg, Christopher B Harrison, Nicholas P Kwiatkowski, Ralph Mazitschek, James E Bradner, Olaf Wiest.   

Abstract

The development of class- and isoform-selective histone deacetylase (HDAC) inhibitors is highly desirable for the study of the complex interactions of these proteins central to transcription regulation as well as for the development of selective HDAC inhibitors as drugs in epigenetics. To provide a structural basis for the rational design of such inhibitors, a combined computational and experimental study of inhibition of three different histone deacetylase isoforms, HDAC1, -6, and -8, with three different hydroxamate inhibitors is reported. While SAHA was found to be unselective for the inhibition of class I and class II HDACs, the other inhibitors were found to be selective toward class II HDACs. Molecular dynamics simulations indicate that this selectivity is caused by both the overall shape of the protein surface leading to the active site and specific interactions of an aspartate residue in a polar loop and two phenylalanines and a methionine in a nonpolar loop. Monitoring the specific interactions as a function of the simulation time identifies a key sulfur-pi interaction. The implications of the structural motifs for the design of class II-selective HDAC inhibitors are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412327     DOI: 10.1021/jm7015254

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  37 in total

1.  Development of a histone deacetylase 6 inhibitor and its biological effects.

Authors:  Ju-Hee Lee; Adaickapillai Mahendran; Yuanshan Yao; Lang Ngo; Gisela Venta-Perez; Megan L Choy; Nathaniel Kim; Won-Seok Ham; Ronald Breslow; Paul A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-10       Impact factor: 11.205

2.  Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.

Authors:  Samuel Bouchet; Camille Linot; Dusan Ruzic; Danica Agbaba; Benoit Fouchaq; Joëlle Roche; Katarina Nikolic; Christophe Blanquart; Philippe Bertrand
Journal:  ACS Med Chem Lett       Date:  2019-05-09       Impact factor: 4.345

3.  On the inhibition of histone deacetylase 8.

Authors:  Guillermina Estiu; Nathan West; Ralph Mazitschek; Edward Greenberg; James E Bradner; Olaf Wiest
Journal:  Bioorg Med Chem       Date:  2010-04-03       Impact factor: 3.641

Review 4.  Chemical probes for histone-modifying enzymes.

Authors:  Philip A Cole
Journal:  Nat Chem Biol       Date:  2008-10       Impact factor: 15.040

5.  The focal adhesion protein kindlin-2 controls mitotic spindle assembly by inhibiting histone deacetylase 6 and maintaining α-tubulin acetylation.

Authors:  Hui-Foon Tan; Suet-Mien Tan
Journal:  J Biol Chem       Date:  2020-03-13       Impact factor: 5.157

6.  The structural requirements of histone deacetylase inhibitors: Suberoylanilide hydroxamic acid analogs modified at the C3 position display isoform selectivity.

Authors:  Sun Ea Choi; Sujith V W Weerasinghe; Mary Kay H Pflum
Journal:  Bioorg Med Chem Lett       Date:  2011-08-12       Impact factor: 2.823

7.  Modular synthesis and biological activity of pyridyl-based analogs of the potent Class I Histone Deacetylase Inhibitor Largazole.

Authors:  Dane J Clausen; William B Smith; Brandon E Haines; Olaf Wiest; James E Bradner; Robert M Williams
Journal:  Bioorg Med Chem       Date:  2015-03-31       Impact factor: 3.641

Review 8.  Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.

Authors:  Michael W Van Dyke
Journal:  ChemMedChem       Date:  2014-01-21       Impact factor: 3.466

9.  Computational exploration of zinc binding groups for HDAC inhibition.

Authors:  Kai Chen; Liping Xu; Olaf Wiest
Journal:  J Org Chem       Date:  2013-04-29       Impact factor: 4.354

Review 10.  Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors.

Authors:  Difei Wang
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.